Knowledge and confidence gains after a COVID-19 vaccine continuing education program developed for nurse...

The COVID-19 pandemic has been marked by rapid innovation in vaccine development. Given that nurse practitioners (NPs) are often involved in vaccine counseling and administration, the American Association of Nurse Practitioners developed a continuing education (CE) series that covered COVID-19 vaccine development, recommendations, administration, and solutions for overcoming hesitancy. In 2020 and 2021, three separate live webinars were delivered; each webinar was updated with the latest vaccine recommendations and was then archived in an enduring format for up to 4 months. The goal of this study was to assess changes in preactivity and postactivity knowledge and confidence and to qualitatively report other learner outcomes. Across the three webinars, 3,580 unique learners who self-reported seeing patients eligible for COVID-19 vaccination completed at least one activity. Knowledge and competence improved from the preactivity to postactivity survey in all webinars, with the overall rates of correct answers increasing by 30% after webinar 1, 37% after webinar 2, and 28% after webinar 3 (all p < .001). Furthermore, mean confidence in learner's ability to address vaccine hesitancy improved across all three webinars (range, 31-32%; all p < .001). The majority of learners indicated that they planned to incorporate lessons from the activity into their clinical practice (range, 85-87%). In postactivity surveys, vaccine hesitancy was identified as an ongoing barrier by up to 33% of learners. In conclusion, this CE activity improved learner knowledge, competence, and confidence related to COVID-19 vaccination and underscores the importance of up-to-date CE targeted to NPs.